Propranolol (Inderal) in Persistent Ventricular Fibrillation

31Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

We report three cases of recurrent episodes of ventricular fibrillation controlled by propranolol (Inderal) given intravenously. In one patient with acute myocardial infarction this treatment was life-saving. Dangers of propranolol may include hypotension, particularly in patients with extensive underlying myocardial damage. In such patients care should be exercised in administering propranolol; a maximum intravenous dose of 10 mg. is recommended. Propranolol was of value in controlling digitalis-induced ventricular fibrillation. Propranolol may be of value as a prophylactic agent in patients with mild myocardial infarction. © 1965, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Sloman, G., Robinson, J. S., & McLean, K. (1965). Propranolol (Inderal) in Persistent Ventricular Fibrillation. British Medical Journal, 1(5439), 895–896. https://doi.org/10.1136/bmj.1.5439.895

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free